Stock Based Compensation - Schedule of Stock Options Outstanding and Exercisable (Details) - 3.3521 [Member] |
12 Months Ended |
|---|---|
|
Dec. 31, 2025
$ / shares
shares
| |
| Schedule of Stock Options Outstanding and Exercisable [Line Items] | |
| Range of Exercise Prices | $ 3.3521 |
| Weighted Average Exercise Price | 3.3521 |
| Options Outstanding [Member] | |
| Schedule of Stock Options Outstanding and Exercisable [Line Items] | |
| Range of Exercise Prices | $ 3.3521 |
| Shares Outstanding (in Shares) | shares | 74,580 |
| Weighted Average Remaining Contractual Life (years) | 6 months |
| Weighted Average Exercise Price | $ 3.3521 |
| Options Exercisable [Member] | |
| Schedule of Stock Options Outstanding and Exercisable [Line Items] | |
| Shares Exercisable (in Shares) | shares | 74,580 |
| Weighted Average Remaining Contractual Life (years) | 6 months |
| Weighted Average Exercise Price | $ 3.3521 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|